(Q36924797)

17 August 2017

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer (English)

1 reference

17 August 2017

10

K Jirström

1 reference

17 August 2017

8

M Uhlén

1 reference

17 August 2017

K Boman

1

1 reference

17 August 2017

A H Larsson

2

1 reference

17 August 2017

U Segersten

3

1 reference

17 August 2017

E Kuteeva

4

1 reference

17 August 2017

H Johannesson

5

1 reference

17 August 2017

B Nodin

6

1 reference

17 August 2017

J Eberhard

7

1 reference

17 August 2017

P-U Malmström

9

1 reference

17 August 2017

language of work or name

English

0 references

publication date

7 May 2013

1 reference

British Journal of Cancer

17 August 2017

1 reference

17 August 2017

108

1 reference

17 August 2017

11

1 reference

17 August 2017

2321-2328

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2013.215

17 August 2017

0 references

cites work

Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Methylation of an intronic region regulates miR-199a in testicular tumor malignancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Urine podocyte mRNAs mark progression of renal disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Expression of the cytoskeleton linker protein ezrin in human cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

T1G3 bladder cancer--indications for early cystectomy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

The treatment of advanced bladder cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Biology and management of bladder cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681027

Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy

4 September 2018

1 reference

12 December 2020

Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions

1 reference

12 December 2020

Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts

1 reference

12 December 2020

Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2013.215

1 reference

17 August 2017

1 reference

17 August 2017

1 reference